Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

37.00
Delayed Data
As of Feb 09
 -0.46 / -1.23%
Today’s Change
36.00
Today|||52-Week Range
51.74
-17.61%
Year-to-Date

Today’s Trading

Previous close37.46
Today’s open36.96
Day’s range36.87 - 37.78
Volume8,691,584
Average volume (3 months)7,161,776
Market cap$55.9B
Dividend yield2.81%
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)+18.58%
Earnings growth (this year)+0.65%
Earnings growth (next 5 years)+10.45%
Revenue growth (last year)+0.78%
P/E ratio22.0
Price/Sales3.31
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.10-0.35%
CELGCelgene+1.32+1.33%
ALXNAlexion Pharmaceutic...-2.69-1.93%
VRXValeant Pharmaceutic...-2.68-2.99%
Data as of 02/09/2016

Financials

Next reporting dateApril 13, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$20.4B
Annual profit (last year)$2.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Senior VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts

Partner Offers